K C E Drechsel, S L Broer, F S Stoutjesdijk, J W R Twisk, M H van den Berg, C B Lambalk, F E van Leeuwen, A Overbeek, M M van den Heuvel-Eibrink, W van Dorp, A C H de Vries, J J Loonen, H J van der Pal, L C Kremer, W J Tissing, B Versluys, G J L Kaspers, E van Dulmen-den Broeder, M A Veening
PURPOSE: To evaluate the impact of treatment for Hodgkin lymphoma (HL) on clinical reproductive markers and pregnancy outcomes. METHODS: This study was embedded within the DCOG LATER-VEVO study; a Dutch, multicenter, retrospective cohort study between 2004 and 2014. Serum anti-Müllerian hormone (AMH), follicle stimulating hormone (FSH), inhibin B, antral follicle count (AFC), and self-reported (first) pregnancy outcomes were evaluated in female childhood HL survivors and controls...
July 31, 2023: Journal of Cancer Research and Clinical Oncology